CIP

UTSW Spinout InterAct Therapeutics Selected by Cell & Gene Therapy Incubator Program

by | Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE
capital fund
AT&T Announces $200M Venture Capital Fund Investment
by | Jul 6, 2017
The fund is intended to help AT&T find solutions to some of the toughest technology issues facing the nation.
MORE